Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
BAL
0.00%
$13.23
BELLAMY'S AUSTRALIA LIMITED - Charts / Financials
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
Daily Volume | 0 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
0 | 0.0¢ | 0 | 0 | 0.0¢ | 0 |
Directors & Senior Management
Mr. Andrew Cohen | Chief Executive Officer, Chief Operating Officer |
Mr. Nigel Underwood | Chief Financial Officer |
Melinda Harrison | General Counsel, Secretary |
Mr. John Ho | Non-Executive Chairman of the Board |
Mr. John Murphy | Independent Non-Executive Deputy Chairman of the Board |
David Director | Director of Sales and Marketing |
Peter Fridell | Director of Operations |
Mr. Rodd Peters | Non-Executive Director |
Data source: Refinitiv